|
APH1B expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.597240E-01 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.381200E-01 |
| Normal-vs-Stage2 |
9.574000E-01 |
| Normal-vs-Stage3 |
8.180300E-02 |
| Normal-vs-Stage4 |
2.030200E-02 |
| Stage1-vs-Stage2 |
3.094800E-01 |
| Stage1-vs-Stage3 |
3.926600E-01 |
| Stage1-vs-Stage4 |
1.242150E-01 |
| Stage2-vs-Stage3 |
1.391770E-01 |
| Stage2-vs-Stage4 |
5.453600E-02 |
| Stage3-vs-Stage4 |
3.977200E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
6.402100E-02 |
| Normal-vs-AfricanAmerican |
2.298800E-01 |
| Normal-vs-Asian |
2.768200E-01 |
| Caucasian-vs-AfricanAmerican |
9.513000E-01 |
| Caucasian-vs-Asian |
7.030800E-01 |
| AfricanAmerican-vs-Asian |
7.717000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.568290E-02 |
| Normal-vs-Female |
3.284800E-01 |
| Male-vs-Female |
3.716100E-02 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.257800E-01 |
| Normal-vs-Age(41-60Yrs) |
1.741380E-01 |
| Normal-vs-Age(61-80Yrs) |
2.594800E-01 |
| Normal-vs-Age(81-100Yrs) |
5.618100E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.987400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.714400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.212200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.760200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.171600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.483960E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
5.377100E-03 |
| Classical-VS-Follicular |
3.554000E-02 |
| Classical-VS-Other |
9.343400E-01 |
| Classical-VS-Normal |
9.809700E-02 |
| Tall-VS-Follicular |
2.355500E-04 |
| Tall-VS-Other |
2.505200E-01 |
| Tall-VS-Normal |
1.299600E-03 |
| Follicular-VS-Other |
4.781000E-01 |
| Follicular-VS-Normal |
6.492600E-01 |
| Other-VS-Normal |
4.670000E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.697400E-01 |
| Normal-vs-N1 |
1.177640E-02 |
| N0-vs-N1 |
4.050300E-02 |
|
|
